Northcape Wealth Management’s Novartis NVS Stock Holding History

Northcape Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.3M	Sell	8,271 -99	-1%	-$14.8K	0.34%	64
2026 Q1	$1.28M	Hold	8,370	–	–	0.35%	66
2025 Q4	$1.15M	Hold	8,370	–	–	0.33%	70
2025 Q3	$1.07M	Hold	8,370	–	–	0.31%	71
2025 Q2	$1.01M	Hold	8,370	–	–	0.31%	69
2025 Q1	$933K	Sell	8,370 -200	-2%	-$21.3K	0.3%	69
2024 Q4	$834K	Hold	8,570	–	–	0.27%	73
2024 Q3	$986K	Hold	8,570	–	–	0.32%	69
2024 Q2	$912K	Buy	8,570 +998	+13%	+$100K	0.33%	70
2024 Q1	$732K	Sell	7,572 -1,690	-18%	-$173K	0.27%	77
2023 Q4	$935K	Sell	9,262 -94	-1%	-$9.07K	0.34%	71
2023 Q3	$953K	Sell	9,356 -496	-5%	-$50.3K	0.37%	71
2023 Q2	$994K	Sell	9,852 -127	-1%	-$12.7K	0.36%	70
2023 Q1	$918K	Buy	+9,979	New	+$872K	0.33%	73
2022 Q4	–	Sell	-11,605	Closed	-$882K	–	117
2022 Q3	$882K	Buy	11,605 +3,233	+39%	+$268K	0.31%	74
2022 Q2	$708K	Sell	8,372 -3,271	-28%	-$287K	0.27%	71
2022 Q1	$1.02M	Buy	11,643 +3,271	+39%	+$283K	0.3%	77
2021 Q4	$732K	Buy	+8,372	New	+$695K	0.25%	71

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Northcape Wealth Management's NVS Position: Q2 2026 in Review

Northcape Wealth Management reduced its Novartis (NVS) stake by 1.2% in Q2 2026, selling an estimated $14.8K and leaving 8,271 shares worth $1.3M. The position accounts for 0.34% of the portfolio, ranked #64.

Northcape Wealth Management first reported a position in NVS in Q4 2021 and has held it in 18 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Northcape Wealth Management held 8,271 shares of Novartis worth $1.3M as of Q2 2026.
Northcape Wealth Management sold 99 Novartis shares in Q2 2026, an estimated $14.8K.
Novartis made up 0.34% of Northcape Wealth Management's portfolio in Q2 2026, its #64 holding.
Northcape Wealth Management first reported a position in Novartis in Q4 2021 and has held it in 18 quarters since.
1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Northcape Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.